FDA authorizes altered monkeypox dosing regimen to increase doses five-fold

The U.S. Food and Drug Administration has authorized an alternative dosing regimen of the monkeypox vaccine that will increase the total number of doses available five-fold amid a nationwide shortage of the medicine.

Share on FacebookEmail this to someoneShare on Google+Tweet about this on TwitterPrint this pageShare on LinkedInShare on StumbleUponShare on TumblrShare on RedditFlattr the authorPin on PinterestBuffer this pageDigg this